Review: Tiotropium reduces exacerbations and hospitalizations in COPD and improves quality of life

November 2005
ACP Journal Club;Nov/Dec2005, Vol. 143 Issue 3, p59
Academic Journal
This article presents information on a clinical study according to which tiotropium reduces exacerbations and hospitalizations in chronic obstructive pulmonary disease (COPD) and improves quality of life. Randomized controlled trials in any language that included patients less than 35 years of age with known stable COPD without evidence of an exacerbation for 1 month before study entry, and compared tiotropium with placebo, ipratropium bromide, or long-acting β-agonists for ≥ 1 month. Studies of patients with diseases other than COPD, previous asthma, cystic fibrosis, bronchiectasis, or other lung diseases were excluded. Exacerbations, hospitalizations for exacerbations, and all-cause mortality.


Related Articles

  • Pulmatrix Hastens COPD Trials Via $14M Series B1 Financing. Boggs, Jennifer // BioWorld Today;8/16/2011, Vol. 22 Issue 158, p1 

    The article discusses trials in chronic obstructive pulmonary disease (COPD) and cystic fibrosis being conducted by Pulmatrix Inc. as it accelerates its development of PUR118. It cites its progress in converting its inhaled cationic airway lining modulator (iCALM) program from liquid...

  • Unravelling salt transport in cystic fibrosis. Noone, P. G.; Southern, K. W. // Thorax;Nov2004, Vol. 59 Issue 11, p916 

    This article presents information related to salt transport in cystic fibrosis (CF). CF is characterized by thick viscid air-way secretions, the development of progressive airways obstruction and bronchiectasis. In patients with CF, the magnitude of sodium absorption across airway epithelia and...

  • cystic fibrosis.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p567 

    An encyclopedia entry for "cystic fibrosis," is presented. Cystic fibrosis is an autosomal recessive disease that is potentially fatal. The disease can manifest itself in many body systems such as the lungs, the pancreas and the skeleton. It can cause chronic obstructive pulmonary disease,...

  • Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease. Hartl, Dominik; Latzin, Philipp; Hordijk, Peter; Marcos, Veronica; Rudolph, Carsten; Woischnik, Markus; Krauss-Etschmann, Susanne; Koller, Barbara; Reinhardt, Dietrich; Roscher, Adelbert A; Roos, Dirk; Griese, Matthias // Nature Medicine;Dec2007, Vol. 13 Issue 12, p1423 

    Interleukin-8 (IL-8) activates neutrophils via the chemokine receptors CXCR1 and CXCR2. However, the airways of individuals with cystic fibrosis are frequently colonized by bacterial pathogens, despite the presence of large numbers of neutrophils and IL-8. Here we show that IL-8 promotes...

  • Cystic fibrosis lung disease: genetic influences, microbial interactions, and radiological assessment. Moskowitz, Samuel M.; Gibson, Ronald L.; Effmann, Eric L. // Pediatric Radiology;Aug2005, Vol. 35 Issue 8, p739 

    Cystic fibrosis (CF) is a multiorgan disease caused by mutation of the CF transmembrane conductance regulator (CFTR) gene. Obstructive lung disease is the predominant cause of morbidity and mortality; thus, most efforts to improve outcomes are directed toward slowing or halting lung-disease...

  • Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis. Oioo, J. C.; Mulrennan, S. A.; KasteIik, J. A.; Morice, A. H.; Redington, A. E. // Thorax;Jan2005, Vol. 60 Issue 1, p22 

    Background: It has been proposed that the ph of airway lining fluid may regulate the fractional exhaled concentration of nitric oxide (FENO) in respiratory disease. Methods: FENO, exhaled breath condensate (BC) ph, and BC concentrations of nitrite plus nitrate (NO2/NO3) were compared in 12...

  • Research outputs in respiratory medicine. Rippon, I.; Lewison, G.; Partridge, M. R. // Thorax;Jan2005, Vol. 60 Issue 1, p63 

    Background: There is currently little information regarding how much the distribution of research activity in respiratory medicine reflects the interests of its clinicians and scientists, the disease burden in any country, or the availability of funding. Methods: A total of 81 419 respiratory...

  • New Test for Lung Disorder. Uehling, Mark D. // Bio-IT World;Aug2004, Vol. 3 Issue 8, p14 

    Reports on a project by Laboratory Corporation of America which aimed to develop a DNA test for the risk factor that leads to chronic obstructive pulmonary disease. Effect of &alpha[sub1[-antitrypsin deficiency (ATT); Significance of a cystic fibrosis test to the ATT project.

  • Evidence that CFTR is expressed in rat tracheal smooth muscle cells and contributes to bronchodilation. Vandebrouck, Clarisse; Melin, Patricia; Norez, Caroline; Robert, Renaud; Guibert, Christelle; Mettey, Yvette; Becq, Frédéric // Respiratory Research;2006, Vol. 7, p113 

    Background: The airway functions are profoundly affected in many diseases including asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF). CF the most common lethal autosomal recessive genetic disease is caused by mutations of the CFTR gene, which normally encodes a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics